Collagenous colitis

Active Ingredient: Budesonide

Indication for Budesonide

Population group: only adults (18 years old or older)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

9 mg once daily in the morning for up to 8 weeks

For:

Dosage regimens

Oral, 9 milligrams budesonide, once daily at morning, over the duration of up to 8 weeks.

Detailed description

The recommended dose is 9 mg once daily in the morning.

Duration of treatment

The duration of treatment should be limited to 8 weeks.

Termination of treatment

The treatment with should not be stopped abruptly, but withdrawn gradually (tapering doses). In the first week, the dosage should be reduced to 6 mg daily, 3 mg in the morning, 3 mg in the evening. In the second week, only 3 mg should be taken in the morning. Afterwards treatment can be stopped.

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.